health

Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers

By
1 Mins read
37
0
Share
Reading Time: < 1 minute

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s (Alamy/PA) -

Drugs that are said to slow the progression of Alzheimer’s disease “make no meaningful difference to patients” while increasing the risk of swelling and bleeding  Read More

37
0
Share
Related posts
health

One in five fathers would resign if forced back to the office

By
1 Mins read
Reading Time: < 1 minuteAlmost one in five fathers currently working from home would resign if their employers mandated a full-time return to the office, new…
health

Hospital probe into why 40 people accessed file of boy attacked by crocodile

By
1 Mins read
Reading Time: < 1 minuteCambridge University Hospitals (CUH) is looking into why around 40 people accessed the medical files of a three-year-old boy taken to hospital…
health

NHS nurse suspended for saying 'stop the boats' and 'deport them all' online

By
1 Mins read
Reading Time: < 1 minuteAn NHS nurse who made a series of offensive social media comments including “stop the boats” and “deport them all” has been suspended for six…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.